|
|
Volumn 312, Issue 5772, 2006, Pages 382-383
|
|
Oseltamivir becomes plentiful--but still not cheap.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETAMIDE DERIVATIVE;
ANTIVIRUS AGENT;
GENERIC DRUG;
OSELTAMIVIR;
ANIMAL;
ARTICLE;
CHEMISTRY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DEVELOPING COUNTRY;
DRUG COST;
DRUG EFFECT;
DRUG INDUSTRY;
ECONOMICS;
HUMAN;
INFLUENZA;
INFLUENZA VIRUS A H5N1;
ORTHOMYXOVIRUS INFECTION;
PATENT;
RANDOMIZED CONTROLLED TRIAL;
SYNTHESIS;
ACETAMIDES;
ANIMALS;
ANTIVIRAL AGENTS;
CHEMISTRY, PHARMACEUTICAL;
DEVELOPING COUNTRIES;
DRUG COSTS;
DRUG INDUSTRY;
DRUGS, GENERIC;
HUMANS;
INFLUENZA A VIRUS, H5N1 SUBTYPE;
INFLUENZA, HUMAN;
ORTHOMYXOVIRIDAE INFECTIONS;
OSELTAMIVIR;
PATENTS;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 33646161228
PISSN: None
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.312.5772.382 Document Type: Article |
|
Times cited : (27)
|
|
References (0)
|
